If you're a patient of Melissa Frei–Jones, M.D., and a MyChart user, you can:
Roberts K.G., Li Y, Payne-Turner D., Harvey R.C., Yang Y.L., Pei D., McCastlain K., Ding L., Lu C., Song G., Ma J., Becksfort J., Rusch M., Chen S.C., Easton J., Cheng J., Boggs K., Santiago-Morales N., Iacobucci I., Fulton R.S., Wen J., Valentine M., Cheng C., Paugh S.W., Devidas M., Chen I.M., Reshmi S., Smith A., Hedlund E., Gupta P., Nagahawatte P., Wu G., Chen X., Yergeau D., Vadodaria B., Mulder H., Winick N.J., Larsen E.C., Carroll W.L., Heerema N.A., Carroll A.J., Grayson G., Tasian S.K., Moore A.S., Keller F., Frei-Jones M., Whitlock J.A., Raetz E.A., White D.L., Hughes T.P., Guidry Auvil J.M., Smith M.A., Marcucci G., Bloomfield C.D., Mrózek K., Kohlschmidt J., Stock W., Kornblau S.M., Konopleva M., Paietta E., Pui C.H., Jeha S., Relling M.V., Evans W.E., Gerhard D.S., Gastier-Foster J.M., Mardis E., Wilson R.K., Loh M.L., Downing J.R., Hunger S.P., Willman C.L., Zhang J., Mullighan C.G. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014 Sep 11;371(11):1005-15. doi: 10.1056/NEJMoa1403088. PMID: 25207766